Curis Lifesciences Ltd.
Closed
NSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
108,000
5.02% |
5.02%
|
₹1.38 |
|
QIB
|
Over 1.00x
|
1,017,000
47.3% |
47.3%
|
₹13.02 |
|
NII / HNI
|
Over 1.00x
|
309,000
14.37% |
14.37%
|
₹3.96 |
|
Retail
|
Over 1.00x
|
716,000
33.3% |
33.3%
|
₹9.16 |
| Total | 1.00x | 2,150,000 |
100% | ₹27.52 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 1,017,000 | ₹13.02 |
47.30%
|
| Market Maker | 108,000 | ₹1.38 |
5.02%
|
| NII | 309,000 | ₹3.96 |
14.37%
|
| Retail | 716,000 | ₹9.16 |
33.30%
|
| Total | 2,150,000 | ₹27.52 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 309,000 | 716,000 | 1,025,000 |
| Allotment price (₹) | 128 | 128 | 128 | 128 | 128 | 128 | 128 | 128 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹9.16 | ₹9.16 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 309,000 | 716,000 | 1,025,000 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 2,000 | ₹256,000 |
| Retail (Max — 13 Lots) | 13 | 13,000 | ₹1,664,000 |
| S-HNI (Min — 14 Lots) | 14 | 14,000 | ₹1,792,000 |
| B-HNI (Min — 68 Lots) | 68 | 68,000 | ₹8,704,000 |
Curis Lifesciences Ltd. is proposing an IPO on NSE SME under the SME category. Total issue: 21,50,000 shares (aggregating up to ₹27.52 Cr).
Opens 07 Nov 2025, closes 11 Nov 2025. Listing: 19 Nov 2025. Apply via ASBA or UPI.
| Particulars | 31 Jul 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 19.51 | 49.65 | 35.87 |
| EBITDA | 4.24 | 9.54 | 8.39 |
| Profit After Tax (PAT) | 2.87 | 6.11 | 4.87 |
| Net Worth | 19.10 | 16.23 | 5.87 |
| Total Assets | 56.29 | 42.53 | 33.88 |
| Reserves & Surplus | 13.16 | 10.29 | 5.37 |
| Borrowings | 15.32 | 15.62 | 17.09 |
| EBITDA Margin (%) | 19.41% | — | — |
| PAT Margin (%) | 12.43% | — | — |
Curis Lifesciences Ltd. IPO is subscribed 1.00 times by Nov 11, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Curis Lifesciences Ltd. IPO retail category is subscribed 1.00 times as of 11 Nov 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 07 Nov 2025 and closes 11 Nov 2025. Min investment: ₹128,000 (1 lot = 1,000 shares). UPI mandate: 2025-11-11.
The Curis Lifesciences Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 17 Nov 2025. Refunds: on 18 Nov 2025.
The Curis Lifesciences Ltd. IPO listing date is 19 Nov 2025, Wednesday. Listed on: NSE SME. Issue price: ₹128. Estimated listing: ₹128. GMP: NIL.
The Curis Lifesciences Ltd. IPO closes on 11 Nov 2025, Tuesday. UPI mandate: 2025-11-11. Allotment: 17 Nov 2025. Listing: 19 Nov 2025.